Matthew S. Abbott - Jun 6, 2023 Form 3 Insider Report for Chemours Co (CC)

Role
SVP, Chief Enterprise Transfor
Signature
/s/ Pauletta Brown, Attorney-in-Fact
Stock symbol
CC
Transactions as of
Jun 6, 2023
Transactions value $
$0
Form type
3
Date filed
6/7/2023, 02:29 PM
Previous filing
May 27, 2021
Next filing
Jun 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
holding CC Common Stock 29,869 Jun 6, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CC Stock Option (Right to Buy) Jun 6, 2023 Common Stock 4,964 $34.84 Direct F2
holding CC Stock Option (Right to Buy) Jun 6, 2023 Common Stock 12,740 $25.98 Direct F3
holding CC Stock Option (Right to Buy) Jun 6, 2023 Common Stock 12,269 $24.01 Direct F4
holding CC Stock Option (Right to Buy) Jun 6, 2023 Common Stock 8,912 $14.43 Direct F5
holding CC Stock Option (Right to Buy) Jun 6, 2023 Common Stock 6,097 $38.02 Direct F5
holding CC Stock Option (Right to Buy) Jun 6, 2023 Common Stock 4,136 $48.53 Direct F5
holding CC Stock Option (Right to Buy) Jun 6, 2023 Common Stock 5,441 $34.72 Direct F5
holding CC Performance Stock Option (Right to Buy) Jun 6, 2023 Common Stock 5,093 $38.32 Direct F2, F6

Explanation of Responses:

Id Content
F1 Includes directly owned shares, restricted stock units and dividend equivalent units.
F2 Options vest in three equal installments beginning on March 1, 2024.
F3 Options vest in three equal installments beginning on March 1, 2023.
F4 Options vest in three equal installments beginning on March 1, 2022.
F5 Options are fully vested.
F6 Represents a 10 percent premium above the closing price of the Company common stock on the date of grant